Skip to main content

Find Clinical Trials

Home
Conditions
Central Nervous System Infections

Clinical trial condition

Central Nervous System Infections

Explore clinical trials studying Central Nervous System Infections. Study availability and eligibility vary by location and protocol.

746 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Central Nervous System Infections trial results

Completed

Pregnancy and Congenital Toxoplasmosis

NCT05774496

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Central Nervous System Parasitic Infections, +22 more
Locations: Service de parasitologie et mycologie médicale Lyon, France

View Trial Details

Completed

Booster Dose of sIPV Co-administered With MMR and HepA-I.

NCT06442449

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Jiangsu Center for Disease Control and Prevention (Jiangsu Institute of Public Health) Nanjing, Jiangsu, China

View Trial Details

Completed

Confirmatory Study of BK1310 in Healthy Infants

NCT03891758

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +30 more
Locations: Investigational Site Fukuoka, Japan

View Trial Details

Completed

Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy

NCT04453917

Conditions: Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +15 more
Locations: CHU Bordeaux Bordeaux, France

CHU Montpellier Montpellier, France

CHU de TOULOUSE Toulouse, France

View Trial Details

Completed

Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)

NCT07297186

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
Locations: Jiangsu Provincial Center for Diseases Control and Prevention Nanjing, Jiangsu, China

View Trial Details

Completed

A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

NCT05850364

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +11 more
Locations: International Centre for Diarrhoeal Disease Research, Bangladesh Dhaka, Bangladesh

Central Hospital Gujranwala, Pakistan

The Aga Khan University Karachi, Pakistan

View Trial Details

Completed

Evaluation of New Biomarker-based Approaches for Improving the Diagnosis of Childhood Tuberculous Meningitis

NCT04308928

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +15 more
Locations: Stellenbosch University Immunology Research Group Cape Town, Western Cape, South Africa

View Trial Details

Completed

EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study

NCT07281105

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +26 more
Locations: Cleveland Clinic Cleveland, Ohio, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

UT Health Houston Houston, Texas, United States

View Trial Details

Completed

NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy

NCT04781309

Conditions: Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

NCT04201262

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +26 more
Locations: Research Site Aurora, Colorado, United States

Research Site Fort Collins, Colorado, United States

Research Site Washington D.C., District of Columbia, United States

Research Site Miami, Florida, United States

View all 41 locations

View Trial Details